Viewray Stock Predictions

Healthcare > Medical - Devices

Buy VRAY

*Your capital is at risk

$0.0250

+0 (+0%)

At Close: Nov 20, 2023

Currently predicting for Mon, 8 Jun 2026

VRAY Prediction Chart

VRAY Predictions History

Latest community submissions for VRAY.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
NameNotImportant Pro	May 2, 2019	$6.98 +3.10%	$6.77	X	96.90%	0
NameNotImportant Pro	Apr 29, 2019	$6.97 -0.14%	$6.98	X	99.86%	5

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VRAY with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT VIEWRAY INC

ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hos...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by